Exploring the lung-gut direction of the gut-lung axis in patients with ARDS.
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
27 May 2024
27 May 2024
Historique:
received:
12
03
2024
accepted:
22
05
2024
medline:
28
5
2024
pubmed:
28
5
2024
entrez:
27
5
2024
Statut:
epublish
Résumé
Acute respiratory distress syndrome (ARDS) represents a life-threatening inflammatory reaction marked by refractory hypoxaemia and pulmonary oedema. Despite advancements in treatment perspectives, ARDS still carries a high mortality rate, often due to systemic inflammatory responses leading to multiple organ dysfunction syndrome (MODS). Indeed, the deterioration and associated mortality in patients with acute lung injury (LI)/ARDS is believed to originate alongside respiratory failure mainly from the involvement of extrapulmonary organs, a consequence of the complex interaction between initial inflammatory cascades related to the primary event and ongoing mechanical ventilation-induced injury resulting in multiple organ failure (MOF) and potentially death. Even though recent research has increasingly highlighted the role of the gastrointestinal tract in this process, the pathophysiology of gut dysfunction in patients with ARDS remains mainly underexplored. This review aims to elucidate the complex interplay between lung and gut in patients with LI/ARDS. We will examine various factors, including systemic inflammation, epithelial barrier dysfunction, the effects of mechanical ventilation (MV), hypercapnia, and gut dysbiosis. Understanding these factors and their interaction may provide valuable insights into the pathophysiology of ARDS and potential therapeutic strategies to improve patient outcomes.
Identifiants
pubmed: 38802959
doi: 10.1186/s13054-024-04966-4
pii: 10.1186/s13054-024-04966-4
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
179Informations de copyright
© 2024. The Author(s).
Références
Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet. 2021;398(10300):622–37.
pubmed: 34217425
pmcid: 8248927
doi: 10.1016/S0140-6736(21)00439-6
Montgomery AB. Early description of ARDS. Chest. 1991;99(1):261–2.
pubmed: 1984975
doi: 10.1378/chest.99.1.261
Ashbaugh DG, et al. Acute respiratory distress in adults. Lancet. 1967;2(7511):319–23.
pubmed: 4143721
doi: 10.1016/S0140-6736(67)90168-7
Bernard GR, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med. 1994;20(3):225–32.
pubmed: 8014293
doi: 10.1007/BF01704707
Force ADT, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–33.
Ferguson ND, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573–82.
pubmed: 22926653
doi: 10.1007/s00134-012-2682-1
Abe T, et al. Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries. Crit Care. 2018;22(1):195.
pubmed: 30115127
pmcid: 6097245
doi: 10.1186/s13054-018-2126-6
Fan EKY, Fan J. Regulation of alveolar macrophage death in acute lung inflammation. Respir Res. 2018;19(1):50.
pubmed: 29587748
pmcid: 5872399
doi: 10.1186/s12931-018-0756-5
Fernando SM, et al. Diagnosis and management of acute respiratory distress syndrome. CMAJ. 2021;193(21):E761–8.
pubmed: 34035056
pmcid: 8177922
doi: 10.1503/cmaj.202661
Putensen C, Wrigge H, Hering R. The effects of mechanical ventilation on the gut and abdomen. Curr Opin Crit Care. 2006;12(2):160–5.
pubmed: 16543794
doi: 10.1097/01.ccx.0000216585.54502.eb
Calfee CS, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018;6(9):691–8.
pubmed: 30078618
pmcid: 6201750
doi: 10.1016/S2213-2600(18)30177-2
Calfee CS, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611–20.
pubmed: 24853585
pmcid: 4154544
doi: 10.1016/S2213-2600(14)70097-9
Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery. 2002;131(3):241–4.
pubmed: 11894026
doi: 10.1067/msy.2002.116408
Mittal R, Coopersmith CM. Redefining the gut as the motor of critical illness. Trends Mol Med. 2014;20(4):214–23.
pubmed: 24055446
doi: 10.1016/j.molmed.2013.08.004
Gatt M, Reddy BS, MacFie J. Review article: bacterial translocation in the critically ill–evidence and methods of prevention. Aliment Pharmacol Ther. 2007;25(7):741–57.
pubmed: 17373913
doi: 10.1111/j.1365-2036.2006.03174.x
Reintam A, Kern H, Starkopf J. Defining gastrointestinal failure. Acta Clin Belg. 2007;62(Suppl 1):168–72.
pubmed: 17469716
doi: 10.1179/acb.2007.62.s1.022
Louis K, et al. Bacterial translocation in an experimental model of multiple organ dysfunctions. J Surg Res. 2013;183(2):686–94.
pubmed: 23481560
doi: 10.1016/j.jss.2013.01.064
Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunction in critical illness. Crit Care Clin. 2016;32(2):203–12.
pubmed: 27016162
pmcid: 4808565
doi: 10.1016/j.ccc.2015.11.004
Nath S, Kitsios GD, Bos LDJ. Gut-lung crosstalk during critical illness. Curr Opin Crit Care. 2023;29(2):130–7.
pubmed: 36762684
doi: 10.1097/MCC.0000000000001015
Adelman MW, et al. The gut microbiome’s role in the development, maintenance, and outcomes of sepsis. Crit Care. 2020;24(1):278.
pubmed: 32487252
pmcid: 7266132
doi: 10.1186/s13054-020-02989-1
Mukherjee S, Hanidziar D. More of the gut in the lung: how two microbiomes meet in ARDS. Yale J Biol Med. 2018;91(2):143–9.
pubmed: 29955219
pmcid: 6020735
Zhou P, et al. The gut-lung axis in critical illness: microbiome composition as a predictor of mortality at day 28 in mechanically ventilated patients. BMC Microbiol. 2023;23(1):399.
pubmed: 38110878
pmcid: 10726596
doi: 10.1186/s12866-023-03078-3
Ziaka M, Exadaktylos A. Pathophysiology of acute lung injury in patients with acute brain injury: the triple-hit hypothesis. Crit Care. 2024;28(1):71.
pubmed: 38454447
pmcid: 10918982
doi: 10.1186/s13054-024-04855-w
Ziaka M, Exadaktylos A. Brain–lung interactions and mechanical ventilation in patients with isolated brain injury. Crit Care. 2021;25(1):358.
pubmed: 34645485
pmcid: 8512596
doi: 10.1186/s13054-021-03778-0
Meduri GU, et al. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest. 2009;136(6):1631–43.
pubmed: 19801579
doi: 10.1378/chest.08-2408
Ziaka M, Exadaktylos A. ARDS associated acute brain injury: from the lung to the brain. Eur J Med Res. 2022;27(1):150.
pubmed: 35964069
pmcid: 9375183
doi: 10.1186/s40001-022-00780-2
Ranieri VM, et al. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA. 2000;284(1):43–4.
pubmed: 10872010
doi: 10.1001/jama.284.1.43
Chaudhuri D, et al. Focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia. Crit Care Med. 2024;52(5):e219–33.
pubmed: 38240492
doi: 10.1097/CCM.0000000000006172
Bellani G, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800.
pubmed: 26903337
doi: 10.1001/jama.2016.0291
Lelubre C, Vincent JL. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 2018;14(7):417–27.
pubmed: 29691495
doi: 10.1038/s41581-018-0005-7
Vermeij JD, et al. Traumatic brain injury in rats induces lung injury and systemic immune suppression. J Neurotrauma. 2013;30(24):2073–9.
pubmed: 23937270
doi: 10.1089/neu.2013.3060
Bird MD, Kovacs EJ. Organ-specific inflammation following acute ethanol and burn injury. J Leukoc Biol. 2008;84(3):607–13.
pubmed: 18362209
pmcid: 2516898
doi: 10.1189/jlb.1107766
Ziaka M, Exadaktylos A. The heart is at risk: understanding stroke-heart–brain interactions with focus on neurogenic stress cardiomyopathy—a review. J Stroke. 2023;25(1):39–54.
pubmed: 36592971
pmcid: 9911836
doi: 10.5853/jos.2022.02173
Westrom B, et al. The immature gut barrier and its importance in establishing immunity in newborn mammals. Front Immunol. 2020;11:1153.
pubmed: 32582216
pmcid: 7296122
doi: 10.3389/fimmu.2020.01153
Assimakopoulos SF, et al. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infection. 2018;46(6):751–60.
pubmed: 30003491
doi: 10.1007/s15010-018-1178-5
Chang M, et al. Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine. PLoS ONE. 2012;7(6): e40087.
pubmed: 22768227
pmcid: 3387149
doi: 10.1371/journal.pone.0040087
Yoseph BP, et al. Mechanisms of intestinal barrier dysfunction in sepsis. Shock. 2016;46(1):52–9.
pubmed: 27299587
pmcid: 4910519
doi: 10.1097/SHK.0000000000000565
Li Q, et al. Disruption of tight junctions during polymicrobial sepsis in vivo. J Pathol. 2009;218(2):210–21.
pubmed: 19235836
doi: 10.1002/path.2525
Gunzel D. Claudins: vital partners in transcellular and paracellular transport coupling. Pflugers Arch. 2017;469(1):35–44.
pubmed: 27888337
doi: 10.1007/s00424-016-1909-3
Lorentz CA, et al. Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis. Mol Med. 2017;23:155–65.
pubmed: 28598488
pmcid: 5568914
doi: 10.2119/molmed.2016.00256
Al-Sadi R, et al. Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene. PLoS ONE. 2014;9(3): e85345.
pubmed: 24662742
pmcid: 3963839
doi: 10.1371/journal.pone.0085345
Zhang X, Jiang X. Effects of enteral nutrition on the barrier function of the intestinal mucosa and dopamine receptor expression in rats with traumatic brain injury. JPEN J Parenter Enteral Nutr. 2015;39(1):114–23.
pubmed: 24047867
doi: 10.1177/0148607113501881
Stoecklein VM, Osuka A, Lederer JA. Trauma equals danger–damage control by the immune system. J Leukoc Biol. 2012;92(3):539–51.
pubmed: 22654121
pmcid: 3427603
doi: 10.1189/jlb.0212072
Panzer AR, et al. Lung microbiota is related to smoking status and to development of acute respiratory distress syndrome in critically ill trauma patients. Am J Respir Crit Care Med. 2018;197(5):621–31.
pubmed: 29035085
pmcid: 6005235
doi: 10.1164/rccm.201702-0441OC
Deitch EA. Gut-origin sepsis: evolution of a concept. Surgeon. 2012;10(6):350–6.
pubmed: 22534256
pmcid: 3413774
doi: 10.1016/j.surge.2012.03.003
Anthony DC, et al. The systemic response to brain injury and disease. Brain Behav Immun. 2012;26(4):534–40.
pubmed: 22085588
doi: 10.1016/j.bbi.2011.10.011
Ziaka M, et al. High-tidal-volume mechanical ventilation and lung inflammation in intensive care patients with normal lungs. Am J Crit Care. 2020;29(1):15–21.
pubmed: 31968080
doi: 10.4037/ajcc2020161
Tremblay LN, Slutsky AS. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians. 1998;110(6):482–8.
pubmed: 9824530
Slutsky AS, Tremblay LN. Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med. 1998;157(6 Pt 1):1721–5.
pubmed: 9620897
doi: 10.1164/ajrccm.157.6.9709092
Plotz FB, et al. Ventilator-induced lung injury and multiple system organ failure: a critical review of facts and hypotheses. Intensive Care Med. 2004;30(10):1865–72.
pubmed: 15221129
doi: 10.1007/s00134-004-2363-9
Vlahakis NE, et al. Stretch induces cytokine release by alveolar epithelial cells in vitro. Am J Physiol. 1999;277(1):L167–73.
pubmed: 10409244
Madahar P, Beitler JR. Emerging concepts in ventilation-induced lung injury. F1000Res. 2020;9:F1000 Faculty Rev-222.
pubmed: 32269759
pmcid: 7111496
doi: 10.12688/f1000research.20576.1
Ranieri VM, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282(1):54–61.
pubmed: 10404912
doi: 10.1001/jama.282.1.54
Pinheiro de Oliveira R, et al. Mechanical ventilation with high tidal volume induces inflammation in patients without lung disease. Crit Care. 2010;14(2):R39.
pubmed: 20236550
pmcid: 2887148
doi: 10.1186/cc8919
Chen L, et al. Molecular mechanisms of ventilator-induced lung injury. Chin Med J. 2018;131:1225–31.
pubmed: 29553050
pmcid: 5956775
doi: 10.4103/0366-6999.226840
Kuipers MT, et al. High levels of S100A8/A9 proteins aggravate ventilator-induced lung injury via TLR4 signaling. PLoS ONE. 2013;8(7): e68694.
pubmed: 23874727
pmcid: 3715539
doi: 10.1371/journal.pone.0068694
Nickles HT, et al. Mechanical ventilation causes airway distension with proinflammatory sequelae in mice. Am J Physiol Lung Cell Mol Physiol. 2014;307(1):L27-37.
pubmed: 24816486
doi: 10.1152/ajplung.00288.2013
Lex D, Uhlig S. One-hit models of ventilator-induced lung injury: benign inflammation versus inflammation as a by-product. Anesthesiology. 2017;126(5):909–22.
pubmed: 28277372
doi: 10.1097/ALN.0000000000001605
Wang X, et al. High-mobility group box 1 protein is involved in the protective effect of Saquinavir on ventilation-induced lung injury in mice. Acta Biochim Biophys Sin (Shanghai). 2017;49(10):907–15.
pubmed: 28981603
doi: 10.1093/abbs/gmx085
Darmon M, et al. Acute respiratory distress syndrome and risk of AKI among critically ill patients. Clin J Am Soc Nephrol. 2014;9(8):1347–53.
pubmed: 24875195
pmcid: 4123396
doi: 10.2215/CJN.08300813
Joannidis M, et al. Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Med. 2020;46(4):654–72.
pubmed: 31820034
doi: 10.1007/s00134-019-05869-7
Hegeman MA, et al. Ventilator-induced endothelial activation and inflammation in the lung and distal organs. Crit Care. 2009;13(6):R182.
pubmed: 19917112
pmcid: 2811914
doi: 10.1186/cc8168
Turon M, et al. Mechanisms involved in brain dysfunction in mechanically ventilated critically ill patients: implications and therapeutics. Ann Transl Med. 2018;6(2):30.
pubmed: 29430447
pmcid: 5799149
doi: 10.21037/atm.2017.12.10
Guery BP, et al. Ventilation-induced lung injury is associated with an increase in gut permeability. Shock. 2003;19(6):559–63.
pubmed: 12785012
doi: 10.1097/01.shk.0000070738.34700.bf
Clayburgh DR, et al. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Investig. 2006;116(10):2682–94.
pubmed: 17016558
pmcid: 1578628
doi: 10.1172/JCI29218
Marchiando AM, et al. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol. 2010;189(1):111–26.
pubmed: 20351069
pmcid: 2854371
doi: 10.1083/jcb.200902153
Fischer A, et al. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-alpha on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2013;304(11):G970–9.
pubmed: 23538493
doi: 10.1152/ajpgi.00183.2012
Feng Y, Teitelbaum DH. Tumour necrosis factor-induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition. J Physiol. 2013;591(15):3709–23.
pubmed: 23753529
pmcid: 3752452
doi: 10.1113/jphysiol.2013.253518
Ye D, Ma TY. Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity. J Cell Mol Med. 2008;12(4):1331–46.
pubmed: 18363837
pmcid: 3865676
doi: 10.1111/j.1582-4934.2008.00302.x
Ding N, et al. Systemic cytokines inhibition with Imp7 siRNA nanoparticle ameliorates gut injury in a mouse model of ventilator-induced lung injury. Biomed Pharmacother. 2023;165: 115237.
pubmed: 37516020
doi: 10.1016/j.biopha.2023.115237
Imai Y, et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA. 2003;289(16):2104–12.
pubmed: 12709468
doi: 10.1001/jama.289.16.2104
Haglund U, Fiddian-Green RG. Assessment of adequate tissue oxygenation in shock and critical illness: oxygen transport in sepsis, Bermuda, April 1 + 2, 1989. Intensive Care Med. 1989;15(7):475–7.
pubmed: 2600294
doi: 10.1007/BF00255606
Acute Respiratory Distress Syndrome, N, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301–8.
doi: 10.1056/NEJM200005043421801
Bruhn A, et al. Effects of positive end-expiratory pressure on gastric mucosal perfusion in acute respiratory distress syndrome. Crit Care. 2004;8(5):R306–11.
pubmed: 15469573
pmcid: 1065018
doi: 10.1186/cc2905
Liebman PR, et al. The mechanism of depressed cardiac output on positive end-expiratory pressure (PEEP). Surgery. 1978;83(5):594–8.
pubmed: 347615
Dorinsky PM, Whitcomb ME. The effect of PEEP on cardiac output. Chest. 1983;84(2):210–6.
pubmed: 6347545
Pick RA, et al. The cardiovascular effect of positive end-expiratory pressure. Chest. 1982;82(3):345–50.
pubmed: 7049595
doi: 10.1378/chest.82.3.345
Berendes E, et al. Effects of positive end-expiratory pressure ventilation on splanchnic oxygenation in humans. J Cardiothorac Vasc Anesth. 1996;10(5):598–602.
pubmed: 8841866
doi: 10.1016/S1053-0770(96)80136-4
Winso O, et al. Portal blood flow in man during graded positive end-expiratory pressure ventilation. Intensive Care Med. 1986;12(2):80–5.
pubmed: 3517099
doi: 10.1007/BF00254516
Trager K, Radermacher P, Georgieff M. PEEP and hepatic metabolic performance in septic shock. Intensive Care Med. 1996;22(11):1274–5.
pubmed: 9120128
doi: 10.1007/BF01709351
Kiefer P, et al. Effect of positive end-expiratory pressure on splanchnic perfusion in acute lung injury. Intensive Care Med. 2000;26(4):376–83.
pubmed: 10872128
doi: 10.1007/s001340051170
Beyer J, et al. The effect of PEEP ventilation on hemodynamics and regional blood flow with special regard to coronary blood flow. Thorac Cardiovasc Surg. 1980;28(2):128–32.
pubmed: 6156499
doi: 10.1055/s-2007-1022063
Akinci IO, et al. Gastric intramucosal pH is stable during titration of positive end-expiratory pressure to improve oxygenation in acute respiratory distress syndrome. Crit Care. 2003;7(3):R17-23.
pubmed: 12793886
pmcid: 270676
doi: 10.1186/cc2172
Suarez-Sipmann F, Ferrando C, Villar J. PEEP titration guided by transpulmonary pressure: lessons from a negative trial. J Thorac Dis. 2019;11(Suppl 15):S1957–62.
pubmed: 31632797
pmcid: 6783792
doi: 10.21037/jtd.2019.08.03
Heunks L, Piquilloud L, Demoule A. How we approach titrating PEEP in patients with acute hypoxemic failure. Crit Care. 2023;27(1):415.
pubmed: 37907983
pmcid: 10617097
doi: 10.1186/s13054-023-04694-1
Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest. 2001;119(4):1222–41.
pubmed: 11296191
doi: 10.1378/chest.119.4.1222
Myeong LJ, Pinsky MR. Cardiovascular interactions in respiratory failure. In: Webb A, editor. Oxford textbook of critical care. Oxford: Oxford Academic; 2016.
Carvalho CR, et al. Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDS. Am J Respir Crit Care Med. 1997;156(5):1458–66.
pubmed: 9372661
doi: 10.1164/ajrccm.156.5.9604081
Stubs CC, et al. Acute, short-term hypercapnia improves microvascular oxygenation of the colon in an animal model of sepsis. Microvasc Res. 2013;90:180–6.
pubmed: 23916914
doi: 10.1016/j.mvr.2013.07.008
Beck C, et al. The beneficial effects of acute hypercapnia on microcirculatory oxygenation in an animal model of sepsis are independent of K(+)ATP channels. Microvasc Res. 2015;99:78–85.
pubmed: 25758765
doi: 10.1016/j.mvr.2015.02.009
Sitbon P, et al. Effects of tidal volume reduction in acute respiratory distress syndrome on gastric mucosal perfusion. Intensive Care Med. 2001;27(5):911–5.
pubmed: 11430549
doi: 10.1007/s001340100931
Sertaridou E, et al. Gut failure in critical care: old school versus new school. Ann Gastroenterol. 2015;28(3):309–22.
pubmed: 26130136
pmcid: 4480167
Qin X, et al. Hydrophobicity of mucosal surface and its relationship to gut barrier function. Shock. 2008;29(3):372–6.
pubmed: 17693944
doi: 10.1097/SHK.0b013e3181453f4e
Huffnagle GB, Dickson RP, Lukacs NW. The respiratory tract microbiome and lung inflammation: a two-way street. Mucosal Immunol. 2017;10(2):299–306.
pubmed: 27966551
doi: 10.1038/mi.2016.108
Dickson RP, et al. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78:481–504.
pubmed: 26527186
doi: 10.1146/annurev-physiol-021115-105238
Gleeson K, Eggli DF, Maxwell SL. Quantitative aspiration during sleep in normal subjects. Chest. 1997;111(5):1266–72.
pubmed: 9149581
doi: 10.1378/chest.111.5.1266
Huxley EJ, et al. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med. 1978;64(4):564–8.
pubmed: 645722
doi: 10.1016/0002-9343(78)90574-0
Hilty M, et al. Disordered microbial communities in asthmatic airways. PLoS ONE. 2010;5(1): e8578.
pubmed: 20052417
pmcid: 2798952
doi: 10.1371/journal.pone.0008578
Budden KF, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017;15(1):55–63.
pubmed: 27694885
doi: 10.1038/nrmicro.2016.142
Martin-Loeches I, et al. The importance of airway and lung microbiome in the critically ill. Crit Care. 2020;24(1):537.
pubmed: 32867808
pmcid: 7457224
doi: 10.1186/s13054-020-03219-4
Kelly BJ, et al. Composition and dynamics of the respiratory tract microbiome in intubated patients. Microbiome. 2016;4:7.
pubmed: 26865050
pmcid: 4750361
doi: 10.1186/s40168-016-0151-8
Shukla SD, et al. Microbiome effects on immunity, health and disease in the lung. Clin Transl Immunol. 2017;6(3): e133.
doi: 10.1038/cti.2017.6
Yagi K, et al. The lung microbiome during health and disease. Int J Mol Sci. 2021;22(19):10872.
pubmed: 34639212
pmcid: 8509400
doi: 10.3390/ijms221910872
Dickson RP. The microbiome and critical illness. Lancet Respir Med. 2016;4(1):59–72.
pubmed: 26700442
doi: 10.1016/S2213-2600(15)00427-0
Agudelo-Ochoa GM, et al. Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis. Gut Microbes. 2020;12(1):1707610.
pubmed: 31924126
pmcid: 7524144
doi: 10.1080/19490976.2019.1707610
Szychowiak P, et al. The role of the microbiota in the management of intensive care patients. Ann Intensive Care. 2022;12(1):3.
pubmed: 34985651
pmcid: 8728486
doi: 10.1186/s13613-021-00976-5
Zakharkina T, et al. The dynamics of the pulmonary microbiome during mechanical ventilation in the intensive care unit and the association with occurrence of pneumonia. Thorax. 2017;72(9):803–10.
pubmed: 28100714
doi: 10.1136/thoraxjnl-2016-209158
Akrami K, Sweeney DA. The microbiome of the critically ill patient. Curr Opin Crit Care. 2018;24(1):49–54.
pubmed: 29257783
doi: 10.1097/MCC.0000000000000469
Kyo M, et al. Unique patterns of lower respiratory tract microbiota are associated with inflammation and hospital mortality in acute respiratory distress syndrome. Respir Res. 2019;20(1):246.
pubmed: 31694652
pmcid: 6836399
doi: 10.1186/s12931-019-1203-y
Enaud R, et al. The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks. Front Cell Infect Microbiol. 2020;10:9.
pubmed: 32140452
pmcid: 7042389
doi: 10.3389/fcimb.2020.00009
Gu S, et al. Alterations of the gut microbiota in patients with Coronavirus disease 2019 or H1N1 influenza. Clin Infect Dis. 2020;71(10):2669–78.
pubmed: 32497191
doi: 10.1093/cid/ciaa709
Salameh TJ, et al. Gut microbiome dynamics and associations with mortality in critically ill patients. Gut Pathog. 2023;15(1):66.
pubmed: 38115015
pmcid: 10731755
doi: 10.1186/s13099-023-00567-8
Cuevas P, et al. The lung lesion in four different types of shock in rabbits. Arch Surg. 1972;104(3):319–22.
pubmed: 4551657
doi: 10.1001/archsurg.1972.04180030067015
Wang J, et al. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J Exp Med. 2014;211(12):2397–410.
pubmed: 25366965
pmcid: 4235643
doi: 10.1084/jem.20140625
Deriu E, et al. Influenza virus affects intestinal microbiota and secondary salmonella infection in the gut through type I interferons. PLoS Pathog. 2016;12(5): e1005572.
pubmed: 27149619
pmcid: 4858270
doi: 10.1371/journal.ppat.1005572
Zhou X, Liao Y. Gut-lung crosstalk in sepsis-induced acute lung injury. Front Microbiol. 2021;12: 779620.
pubmed: 35003009
pmcid: 8733643
doi: 10.3389/fmicb.2021.779620
Winter SE, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science. 2013;339(6120):708–11.
pubmed: 23393266
pmcid: 4004111
doi: 10.1126/science.1232467
Grootjans J, et al. Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model. Am J Pathol. 2010;176(5):2283–91.
pubmed: 20348235
pmcid: 2861093
doi: 10.2353/ajpath.2010.091069
Albenberg L, et al. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology. 2014;147(5):1055–63.
pubmed: 25046162
doi: 10.1053/j.gastro.2014.07.020
Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol. 2012;30:759–95.
pubmed: 22224764
pmcid: 4426968
doi: 10.1146/annurev-immunol-020711-074937
Lupp C, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe. 2007;2(3):204.
pubmed: 18030708
doi: 10.1016/j.chom.2007.08.002
Reintam Blaser A, et al. Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine. Crit Care. 2020;24(1):224.
pubmed: 32414423
pmcid: 7226709
doi: 10.1186/s13054-020-02889-4
Reintam Blaser A, et al. Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study. Intensive Care Med. 2013;39(5):899–909.
pubmed: 23370829
pmcid: 3625421
doi: 10.1007/s00134-013-2831-1
Alverdy JC, Krezalek MA. Collapse of the microbiome, emergence of the pathobiome, and the immunopathology of sepsis. Crit Care Med. 2017;45(2):337–47.
pubmed: 28098630
pmcid: 5245179
doi: 10.1097/CCM.0000000000002172
Marrocco F, et al. Short-chain fatty acids promote the effect of environmental signals on the gut microbiome and metabolome in mice. Commun Biol. 2022;5(1):517.
pubmed: 35641653
pmcid: 9156677
doi: 10.1038/s42003-022-03468-9
Vernocchi P, Del Chierico F, Putignani L. Gut microbiota metabolism and interaction with food components. Int J Mol Sci. 2020;21(10):3688.
pubmed: 32456257
pmcid: 7279363
doi: 10.3390/ijms21103688
Everard A, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes. 2011;60(11):2775–86.
pubmed: 21933985
pmcid: 3198091
doi: 10.2337/db11-0227
Vinolo MA, et al. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. 2011;22(9):849–55.
pubmed: 21167700
doi: 10.1016/j.jnutbio.2010.07.009
Wei Y, et al. The intestinal microbial metabolite desaminotyrosine is an anti-inflammatory molecule that modulates local and systemic immune homeostasis. FASEB J. 2020;34(12):16117–28.
pubmed: 33047367
doi: 10.1096/fj.201902900RR
Hill C, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–14.
pubmed: 24912386
doi: 10.1038/nrgastro.2014.66
Gagliardi A, et al. Rebuilding the gut microbiota ecosystem. Int J Environ Res Public Health. 2018;15(8):1679.
pubmed: 30087270
pmcid: 6121872
doi: 10.3390/ijerph15081679
Manzanares W, et al. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care. 2016;19:262.
pubmed: 27538711
doi: 10.1186/s13054-016-1434-y
Suez J, et al. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716–29.
pubmed: 31061539
doi: 10.1038/s41591-019-0439-x
Guan ZW, Yu EZ, Feng Q. Soluble dietary fiber, one of the most important nutrients for the gut microbiota. Molecules. 2021;26(22):6802.
pubmed: 34833893
pmcid: 8624670
doi: 10.3390/molecules26226802
Lopes R, et al. Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre/probiotics in chronic kidney disease: a systematic review. Nutr Hosp. 2018;35(3):722–30.
pubmed: 29974784
Milajerdi A, et al. The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. Eur J Nutr. 2020;59(2):633–49.
pubmed: 30854594
doi: 10.1007/s00394-019-01931-8
Seifi N, et al. Effects of synbiotic supplementation on the serum endotoxin level, inflammatory status, and clinical outcomes of adult patients with critical illness: a randomized controlled trial. Nutr Clin Pract. 2022;37(2):451–8.
pubmed: 34462956
doi: 10.1002/ncp.10758
Kim KO, Gluck M. Fecal microbiota transplantation: an update on clinical practice. Clin Endosc. 2019;52(2):137–43.
pubmed: 30909689
pmcid: 6453848
doi: 10.5946/ce.2019.009
Du D, et al. Fecal microbiota transplantation is a promising method to restore gut microbiota dysbiosis and relieve neurological deficits after traumatic brain injury. Oxid Med Cell Longev. 2021;2021:5816837.
pubmed: 33628361
pmcid: 7894052
doi: 10.1155/2021/5816837
Limketkai BN, et al. Fecal microbiota transplantation for the critically ill patient. Nutr Clin Pract. 2019;34(1):73–9.
pubmed: 30561131
doi: 10.1002/ncp.10228
Keskey R, et al. The use of fecal microbiota transplant in sepsis. Transl Res. 2020;226:12–25.
pubmed: 32649987
pmcid: 7572598
doi: 10.1016/j.trsl.2020.07.002
He S, et al. Gut microbiome-based therapeutics in critically ill adult patients—a narrative review. Nutrients. 2023;15(22):4734.
pubmed: 38004128
pmcid: 10675331
doi: 10.3390/nu15224734